FDA Inspection 1272372 — AbbVie Bioresearch Center
The FDA completed an inspection of AbbVie Bioresearch Center on September 5, 2025 in Worcester, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Worcester, MA (United States)